search
biotechnology
Trends
- 1Startup seeks to prove embryo gene-editing is safe for healthy babies●This startup wants to prove gene-editing embryos is safe for making healthy babies
A startup is working to demonstrate that gene-editing human embryos can be done safely, with the aim of producing babies free of inherited disease. The effort touches one of the most contested areas in biotechnology, where editing of embryos has previously triggered international condemnation, and is likely to reignite debate among scientists, ethicists and regulators about where the line should be drawn.
- 2Healey awards $40M in tax incentives to life science company▼Healey awards $40M in tax incentives to life science company, expected to create 1,600 jobs
Massachusetts Governor Maura Healey has approved $40 million in tax incentives for a life science company, a package state officials say will support the creation of 1,600 jobs. The award is part of the state's ongoing effort to keep and grow its biotechnology and life sciences sector, one of Massachusetts' key industries. Details on the company's identity and expansion site were included in the announcement.
- 3Genesis Mission Report Looks at AI in Fusion and Biology▼Genesis Mission Report Examines AI’s Role in Fusion and Biological Design
A new report from the Genesis Mission examines how artificial intelligence is being applied to fusion energy research and biological design. The analysis covers AI's potential to accelerate scientific discovery in these fields, including modeling complex plasma behavior and engineering biological systems. The report is drawing attention from readers following the broader push to apply advanced computing and AI to national science and energy priorities.
- 4Pittsburgh biotech partners with Boston company to form startup▼Pittsburgh biotech partners with Boston-area company, forming new startup
A Pittsburgh biotechnology company has partnered with a Boston-area firm to launch a new startup, according to the Pittsburgh Post-Gazette. The move links the two regional biotech hubs and could bring combined research and commercial capabilities under one new venture. Details about the companies' names, funding and focus have not yet been widely reported.
- 5
Former Genentech artificial intelligence staff have launched Ortet, a new health-focused startup, backed by $500 million in funding. The company will apply AI to drug discovery and healthcare development, drawing on the founders' experience at one of the world's leading biotechnology firms. The large initial funding round makes Ortet one of the most heavily financed health AI launches to date.
- 6
Biotechnology sector coverage for the third quarter of 2026 is being summarised, rounding up recent developments in the field. Readers are being pointed to a period-end recap of biotech news, though the headline carries no detail on specific companies, therapies, or breakthroughs included in the update.
- 7Scientists refine targeting of cell-surface proteins▼Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.
- 8AllyGPO Wins Stevie Award for Pharma Technology Excellence▼AllyGPO Wins Stevie Award for Technology Excellence in Pharmaceuticals and Biotechnology
AllyGPO has won a Stevie Award for Technology Excellence in the Pharmaceuticals and Biotechnology category. The recognition honours the company's technology work serving the healthcare group purchasing sector. The announcement was made via press release, and details on the specific product or project recognised were not provided.